−13.3502USD
−114.53 MUSD
18.90 M
About Evelo Biosciences, Inc.
Sector
CEO
Craig R. Jalbert
Headquarters
Cambridge
Website
Employees (FY)
66
Founded
2014
ISIN
US2997342025
FIGI
BBG00KLJ2SH8
Evelo Biosciences, Inc. operates as a clinical stage biotechnology company, which engages in the development of orally delivered investigational medicines. Its portfolio includes EDP1066 and EDP1815 for the treatment of inflammatory diseases, EDP2939 for inflammation, and EDP1908 for oncology. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of EVLO is 0.0500 USD — it has increased by 13.77% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Evelo Biosciences, Inc. stocks are traded under the ticker EVLO.
Evelo Biosciences, Inc. is going to release the next earnings report on May 30, 2024. Keep track of upcoming events with our Earnings Calendar.
EVLO stock is 12.10% volatile and has beta coefficient of 3.10. Check out the list of the most volatile stocks — is Evelo Biosciences, Inc. there?
EVLO earnings for the last quarter are −4.59 USD whereas the estimation was −4.60 USD which accounts for 0.33% surprise. Estimated earnings for the next quarter are −3.26 USD. See more details about Evelo Biosciences, Inc. earnings.
Yes, you can track Evelo Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
EVLO stock has risen by 19.33% compared to the previous week, the month change is a 27.54% fall, over the last year Evelo Biosciences, Inc. has showed a 98.45% decrease.
EVLO net income for the last quarter is −12.36 M USD, while the quarter before that showed −21.10 M USD of net income which accounts for 41.41% change. Track more Evelo Biosciences, Inc. financial stats to get the full picture.
Today Evelo Biosciences, Inc. has the market capitalization of 834.29 K, it has decreased by 16.20% over the last week.
No, EVLO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EVLO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Evelo Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 66.00 employees. See our rating of the largest employees — is Evelo Biosciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Evelo Biosciences, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Evelo Biosciences, Inc. stock shows the sell signal. See more of Evelo Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.